Commercial insight into the pharma and biotech sector.
EP Vantage is a daily news service with a difference. Powered by EvaluatePharma®, EP Vantage brings fresh angles & insight on current & future industry triggers using proprietary quantitative analysis.
EP Vantage delivers daily forward-looking comment and analysis, focusing on events that define the commercial future of companies, products and therapy areas:
-
In-depth & incisive analysis of regulatory & patent decisions, marketing approvals, licensing deals and M&A
-
Timely financial analysis of pivotal events put into context with EvaluatePharma market data
-
Advanced intelligence from
Calendar of Events on potential market catalysts weeks & even months ahead of other industry sources
-
Unique access to interactive NPV Analyzer to quantify the impact on product & company valuation
-
EventAnalyzer delivers invaluable insights into the market events impacting global company share prices
-
View individual events by Company, Product, Therapy Area and Peer Group
-
Identify instantly which type of events are impacting company valuations and the news behind share price movement
-
Track the market impact by type of event with over 100 classifications including regulatory approvals, financial results, patent litigation, broker sentiment & competitor announcements
-
Get Daily & Weekly Market Movers alerts offering the most comprehensive daily round up of share price movements plus the story behind the news
Register for a free trial of EP Vantage
" Someone’s actually thought about what’s happened, as opposed to just writing about it...."
Strategy Director, European based global pharmaceutical company